小儿特应性皮炎的当前及新兴疗法
Current and Emerging Therapies in Pediatric Atopic Dermatitis.
作者信息
Johnson Hadley, Yu JiaDe
机构信息
University of Minnesota Medical School, Minneapolis, MN, USA.
Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
出版信息
Dermatol Ther (Heidelb). 2022 Dec;12(12):2691-2703. doi: 10.1007/s13555-022-00829-4. Epub 2022 Oct 18.
Abstract
Atopic dermatitis (AD) is the most common inflammatory skin disease seen in children. It is a heterogeneous disorder, with a variety of associated manifestations and symptoms. Cases may range from mild to severe. As a result, a spectrum of prescription and nonprescription therapies may be utilized when managing this condition. This article provides an extensive overview of these therapies, with equal consideration provided to current, emerging, and alternative options used in the pediatric population.
摘要
特应性皮炎（AD）是儿童中最常见的炎症性皮肤病。它是一种异质性疾病，伴有多种相关表现和症状。病例范围从轻度到重度。因此，在管理这种疾病时可能会使用一系列处方和非处方疗法。本文对这些疗法进行了广泛概述，同时对儿科人群中使用的现有、新兴和替代疗法给予了同等考虑。
相似文献
1
Current and Emerging Therapies in Pediatric Atopic Dermatitis.
Dermatol Ther (Heidelb). 2022 Dec;12(12):2691-2703. doi: 10.1007/s13555-022-00829-4. Epub 2022 Oct 18.
2
Management of Severe Atopic Dermatitis in Pediatric Patients.
J Allergy Clin Immunol Pract. 2021 Apr;9(4):1462-1471. doi: 10.1016/j.jaip.2021.02.017.
3
Current and emerging biologics for the treatment of pediatric atopic dermatitis.
Expert Opin Biol Ther. 2020 Dec;20(12):1435-1445. doi: 10.1080/14712598.2021.1840548. Epub 2020 Nov 15.
4
Physician Perception of Disease Severity and Treatment Outcomes for Children and Adolescents with Atopic Dermatitis in Emerging Economies.
Dermatol Ther (Heidelb). 2022 Apr;12(4):999-1013. doi: 10.1007/s13555-022-00708-y. Epub 2022 Mar 26.
5
Therapy of atopic eczema.
GMS Health Technol Assess. 2006 Oct 6;2:Doc19.
6
Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document. Section I: Pathophysiology of Atopic Dermatitis and Implications for Systemic Therapy.
J Cutan Med Surg. 2018 Nov/Dec;22(1_suppl):6S-9S. doi: 10.1177/1203475418803626.
7
The suitability of treating atopic dermatitis with Janus kinase inhibitors.
Expert Rev Clin Immunol. 2022 May;18(5):439-459. doi: 10.1080/1744666X.2022.2060822. Epub 2022 May 4.
8
Inadequate Disease Control, Treatment Dissatisfaction, and Quality-of-Life Impairments Among US Patients Receiving Topical Therapy for Atopic Dermatitis.
Dermatol Ther (Heidelb). 2021 Oct;11(5):1571-1585. doi: 10.1007/s13555-021-00580-2. Epub 2021 Jul 15.
9
JAK/STAT inhibitors for the treatment of atopic dermatitis.
J Dermatolog Treat. 2020 Feb;31(1):33-40. doi: 10.1080/09546634.2019.1577549. Epub 2019 Feb 18.
10
Biological Therapies for Atopic Dermatitis: A Systematic Review.
Dermatology. 2021;237(4):542-552. doi: 10.1159/000514535. Epub 2021 Mar 18.
引用本文的文献
1
Managing Childhood and Adolescent Atopic Dermatitis in Primary Care: A US Expert Group Consensus.
J Pediatr Clin Pract. 2024 Jul 10;14:200121. doi: 10.1016/j.jpedcp.2024.200121. eCollection 2024 Dec.
2
Improving Psychological Health Outcomes in Children with Atopic Dermatitis.
Clin Cosmet Investig Dermatol. 2023 Oct 10;16:2821-2827. doi: 10.2147/CCID.S393254. eCollection 2023.
3
Zn-MOF hydrogel: regulation of ROS-mediated inflammatory microenvironment for treatment of atopic dermatitis.
J Nanobiotechnology. 2023 May 22;21(1):163. doi: 10.1186/s12951-023-01924-0.
4
Single-Strain Probiotic Lactobacilli for the Treatment of Atopic Dermatitis in Children: A Systematic Review and Meta-Analysis.
Pharmaceutics. 2023 Apr 17;15(4):1256. doi: 10.3390/pharmaceutics15041256.
本文引用的文献
1
Impact of gut microbiome on skin health: gut-skin axis observed through the lenses of therapeutics and skin diseases.
Gut Microbes. 2022 Jan-Dec;14(1):2096995. doi: 10.1080/19490976.2022.2096995.
2
Recent insights into the management of treatment-resistant pediatric atopic dermatitis.
Int J Womens Dermatol. 2022 May 25;8(2):e023. doi: 10.1097/JW9.0000000000000023. eCollection 2022 Jun.
3
Keratinocytes: An Enigmatic Factor in Atopic Dermatitis.
Cells. 2022 May 19;11(10):1683. doi: 10.3390/cells11101683.
4
Bleach baths for atopic dermatitis: Evidence of efficacy but more data are needed.
Ann Allergy Asthma Immunol. 2022 Jun;128(6):617-618. doi: 10.1016/j.anai.2022.03.013.
5
Efficacy and safety profile of antioxidants in the treatment of atopic dermatitis: A systematic review and meta-analysis of randomized controlled trials.
Dermatol Ther. 2022 Jul;35(7):e15549. doi: 10.1111/dth.15549. Epub 2022 May 9.
6
Optimizing topical management of atopic dermatitis.
Ann Allergy Asthma Immunol. 2022 May;128(5):488-504. doi: 10.1016/j.anai.2022.03.004. Epub 2022 Mar 12.
7
Consensus Update for Systemic Treatment of Atopic Dermatitis.
Ann Dermatol. 2021 Dec;33(6):497-514. doi: 10.5021/ad.2021.33.6.497. Epub 2021 Nov 4.
8
The Skin Microbiome of Patients With Atopic Dermatitis Normalizes Gradually During Treatment.
Front Cell Infect Microbiol. 2021 Sep 24;11:720674. doi: 10.3389/fcimb.2021.720674. eCollection 2021.
9
Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial.
JAMA Dermatol. 2021 Sep 1;157(9):1047-1055. doi: 10.1001/jamadermatol.2021.3023.
10
Safety of topical corticosteroids in atopic eczema: an umbrella review.
BMJ Open. 2021 Jul 7;11(7):e046476. doi: 10.1136/bmjopen-2020-046476.
Zotero 插件